Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -14.72x is 100% above its 2-year average of -3020.89x, near the high end of its 2-year range (-6027.05x–-14.72x).
As of the fiscal period ended Friday, March 31, 2023.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2023 (2023-03-31): -14.72x.
INTEREST COVERAGE RATIO
-14.72x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-3020.89x
INTEREST COVERAGE RATIO AVG 5Y
-3020.89x
INTEREST COVERAGE RATIO AVG 10Y
-90.27x
INTEREST COVERAGE RATIO AVG 15Y
-78.23x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+99.51%
CURRENT VS 5Y AVG
+99.51%
CURRENT VS 10Y AVG
+83.69%
CURRENT VS 15Y AVG
+81.18%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.97x
median of 292 covered companies
CURRENT VS SECTOR MEDIAN
-394.79%
vs the sector median at left
Anavex Life Sciences Corp.
Market Cap
$152.45M
Interest Coverage Ratio
-14.72x
TTM Avg
N/A
3Y Avg
-3020.89x
5Y Avg
-3020.89x
Market Cap
$152.16M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$153.84M
Interest Coverage Ratio
-29.32x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$149.51M
Interest Coverage Ratio
-7.96x
TTM Avg
23.57x
3Y Avg
23.57x
5Y Avg
23.57x
Market Cap
$146.66M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.49M
Interest Coverage Ratio
-8.06x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.11M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$162.82M
Interest Coverage Ratio
-64.93x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anavex Life Sciences Corp. (AVXL) | $152.45M | -14.72x | N/A | -3020.89x | -3020.89x |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | -29.32x | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $149.51M | -7.96x | 23.57x | 23.57x | 23.57x |
| Immuneering Corporation (IMRX)vs › | $146.66M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.49M | -8.06x | N/A | N/A | N/A |
| Alpha Cognition Inc (ACOG)vs › | $142.11M | N/A | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $162.82M | -64.93x | N/A | N/A | N/A |
| Freenome, Inc. (FRNM)vs › | $137.29M | N/A | N/A | N/A | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $134.74M | -0.80x | 1.46x | 2.93x | 2.25x |
Interest Coverage
-14.7x
Debt/Equity
0.00
Current Ratio
15.62
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-03-31 | -14.72x |
| 2020-12-31 | -6027.05x |
| 2015-12-31 | -1831.13x |
| 2015-09-30 | -2.82x |
| 2015-03-31 | -385.25x |
| 2014-12-31 | -10.01x |
| 2014-09-30 | -0.07x |
| 2014-06-30 | -117.62x |
| 2014-03-31 | -201.06x |
| 2013-12-31 | -94.19x |
| 2013-09-30 | -151.08x |
| 2013-06-30 | -8.48x |
| 2013-03-31 | -7.68x |
| 2012-12-31 | -40.62x |
| 2012-09-30 | -71.98x |
| 2012-06-30 | -13.07x |
| 2012-03-31 | -8.39x |
| 2011-12-31 | -27.16x |
| 2011-09-30 | -16.50x |
| 2011-06-30 | -243.18x |
| 2011-03-31 | -341.82x |
| 2010-12-31 | -136.93x |
| 2010-09-30 | -14.48x |
| 2010-06-30 | -13.59x |
| 2010-03-31 | -44.07x |
| 2009-12-31 | -35.89x |
| 2009-09-30 | -122.21x |
| 2009-06-30 | -215.41x |
| 2009-03-31 | -130.27x |
| 2008-12-31 | -28.91x |
| 2007-12-31 | -641.39x |
